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Abstract 
Purpose: To investigate the electro-reduction behaviour and determination of ciprofloxacin using a 
hanging mercury drop electrode.  
Methods: Cyclic voltammograms of ciprofloxacin recorded in Britton – Robinson buffers pH 2 – 5 exhibit 
a single irreversible cathodic peak. The dependence of the peak current and peak potential values on 
buffer (nature, pH and concentration) and accumulation conditions (time and potential) were examined 
and used for the quantitative analysis of ciprofloxacin in dosage forms and urine. Acetate buffer (0.08 M, 
pH 3.6) was selected as a supporting electrolyte for quantitative purposes by differential pulse and 
square wave adsorptive cathodic stripping voltammetry. 
Results: A reduction wave was seen in the range of – 1.3 to – 1.5 V. These techniques were 
successfully validated as per ICH guidelines and comparable to US Pharmacopoeia HPLC method. The 
techniques was applied to the determination of ciprofloxacin in pharmaceutical formulations (i.e. 
precision (RSD < 1%) and accuracy (99 – 101%)), and was further extended to determine ciprofloxacin 
in spiked human urine with no matrix effect (i.e. LLOQ 0.01 g/ml, precision (RSD < 15%) and accuracy 
(85 – 115%)). 
Conclusion: Validated adsorptive cathodic stripping voltammetric technique can be recommended for 
use in quality control and pharmacokinetics studies. 
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Ciprofloxacin is a second-generation synthetic 
fluoroquinolone antibiotic. Chemically, it is 
described as 1-cyclopropyl-6-fluoro-4-oxo-7-
(piperazin-1-yl)-quinoline-3-carboxylic acid. Since 
being first patented by Bayer AG and 
subsequently approved by US Food and Drug 
Administration in the 1980s, it has been 
commonly used for urinary tract and intestinal 
infections [1]. It is also one of the antibiotics 
recommended by FDA for inhalational anthrax 
post-exposure [2]. This drug is bactericidal over a 
wide range of Gram-positive and Gram-negative 
bacteria via the blockage of cell growth and 
division by interfering with two essential bacterial 
enzymes DNA gyrase and DNA topoisomerase 
IV, which probably leads to the lethal release of 
double-strand DNA breaks [3]. The bioavailable 
salt forms of ciprofloxacin in the market are 
hydrochloride (tablets and eye/ear drops) and 
lactate (intravenous infusion solutions). 
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In literature, the determination of ciprofloxacin in 
pharmaceutical dosage forms is achieved by 
high performance liquid chromatography (HPLC) 
[4], high performance thin layer chromatography 
(HPTLC) [5], spectrophotometry and 
spectrofluorimetry [6,7], potentiometry [8], atomic 
absorption spectrometry [9], Rayleigh light 
scattering technique [10] as well as voltammetry 
[11–14]. 
 
The purpose of this work was to 
electroanalytically investigate the reduction 
mechanism and voltammetric behavior of 
ciprofloxacin at the hanging mercury drop 
electrode, which has not been reported so far, 
using cyclic, differential pulse and square wave 
voltammetry for its quantification in 




Reagents and apparatuses 
 
Ciprofloxacin hydrochloride standard was kindly 
supplied by National Institute of Drug Quality 
Control (Vietnam) and used without further 
purification. A standard stock solution of 500 
g/ml ciprofloxacin was prepared in water and 
protected from light in a refrigerator. This solution 
was stable for at least one week as 
voltammetrically tested. Working standards of 
ciprofloxacin were freshly prepared just before 
the assay by adding appropriate amounts of 
stock solution with concentrated supporting 
electrolytes and water to the mark in 50 ml 
volumetric flasks. Other chemicals were of 
analytical grade and purchased from Merck 
(Germany). Concentrated supporting electrolytes 
were prepared on the day the experiment was 
performed. Urine was collected from healthy 
human was used for ciprofloxacin – spiked 
samples. Freshly prepared de-ionized doubly 
distilled water (Maxima Ultra. Pure Water, Elga-
Prima Corp, UK) was used throughout this study. 
pH measurements were performed on a 
CyberScan pH 510 (Eutech Instruments Pte Ltd., 
Singapore). All voltammetric measurements were 
carried out at 25C with a 797 VA Computrace 
(Metrohm AG, Switzerland) in connection with a 
Dell computer using Microsoft Windows XP and 
controlled by VA Computrace Software 1.3. The 
three – electrode system consisted of a hanging 
mercury drop electrode (HMDE) as working 
electrode, a platinum wire as auxiliary electrode 
and an AgAgClKCl(3 M) as reference electrode. 
A medium size mercury drop was employed. 
Oxygen – free nitrogen gas was used for the 
removal of dissolved oxygen from the measured 
solutions for 100 s with a stirring rate of 2000 
rpm. After a pre-concentration step, the solutions 
were left quiescent for 15 s equilibrium before 
measurement.  
 
To elucidate the characteristics of electrode 
process, the cyclic voltammetric behaviour of 
0.05 g/ml ciprofloxacin in the Britton – Robinson 
universal buffers at the HMDE was studied. The 
experimental parameters were accumulation 
potential – 1.1 V, accumulation time 30 s, scan 
rate 0.1 V/s, pulse step 0.005 V and potential 
range from – 1.1 to – 1.6 V. In this study, 
differential pulse and square wave adsorptive 
cathodic stripping voltammetry (DP-AdCSV and 
SW-AdCSV as respectively abbreviated) were 
taken into account for quantitative purposes. The 
optimization process started with the selection of 
buffer type (i.e. acetate, phosphate and citrate 
buffers pH 3.5) with voltammetric measurements 
of 0.1 g/ml ciprofloxacin. Unless stated 
otherwise, the voltammograms were recorded in 
triplicate for each automatic run. Optimization 
process was carried out using Modde 9.1 
software (Umetrics, Sweden). All experiments 
were performed in a randomized order as 
proposed by the software so as to minimize the 
effect of uncontrolled factors that may introduce 
a bias on the response. To determine the optimal 
factors, the optimizer function of Modde software 




Twenty tablets (Ciprobay 500 mg, Bayer AG, 
Germany) were finely pulverized in a mortar. A 
quantity equivalent to 400 mg ciprofloxacin was 
accurately weighed and dissolved in about 25 mL 
of water in a 50 mL volumetric flask by sonication 
for 20 min, subsequently diluted to the mark with 
the same solvent. For intravenous infusion 
solution 2 mg/mL (Pharbaco Central 
Pharmaceutical Joint Stock Company, Vietnam) 
and eye drops 0.3% (Quindrops, Altomega Drugs 
Pvt., Ltd., India), the content of five bottles or 
vials were well mixed. Appropriate dilutions were 
then made in 50 mL volumetric flasks to obtain 
ca. 0.08 g/mL ciprofloxacin test solution. 
 
Analysis of samples 
 
The general procedure adopted for obtaining 
adsorptive stripping voltammograms was as 
follows. For pharmaceutical formulations, 0.25 
mL of test solution was diluted with 0.1 mL 
concentrated supporting electrolyte solution (i.e. 
0.08 M acetate buffer pH 3.6) and water to the 
mark in a 25 mL volumetric flask. For spiked 
human urine, accurately measured aliquots of 5 
g/mL ml ciprofloxacin were pipetted into 25 mL 
volumetric flasks, subsequently added with 0.1 
mL concentrated supporting electrolyte solution 
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and human urine diluted with water to 1250 times 
to the mark. The content of these flasks was 
completely transferred into the voltammetric cell 
for measurement after shaking for 5 min 




Characteristics of the electrode process 
 
A well-defined single peak was yielded in the 
cathodic direction in the pH range 2 – 5 (Figure 
1). The peak current obtained without 
accumulation was substantially smaller than that 
obtained after a pre-concentration step (data not 
shown). On the other hand, the peak potential 
and current were not appreciably influenced by 
varying the scan rate from 0.03 – 0.1 V/s at 
different pH values. No oxidation peak was 
observed in the positive scanning half-cycle. This 
irreversible cathodic peak disappeared at pH > 5 
(data not shown).  
 
A linear relationship of Ep vs. pH following the 
regression equation: Ep (V) = – 0.067 pH – 1.237 
(R2 = 0.998 and n = 4) was obtained. Its slope 
value equals 67 mV = {(59/)(m/na)}, where na 
and m are the numbers of electrons and protons 
involved in the rate determining step, 




Figure 1: Cyclic voltammograms of 0.05 g/ml 
ciprofloxacin in Britton – Robinson buffers pH 5.0 (a), 
4.1(b), 3.4 (c), 2.5 (d) 
 
Optimal parameters and experimental 
conditions 
 
DP-AdCSV and SW-AdCSV measurements of 
0.1 g/ml ciprofloxacin recorded in acetate, 
phosphate and citrate buffers pH 3.5 only show 
an askew well-defined sharp peak in acetate 
medium. Accordingly, this type of buffer was 
chosen as a supporting electrolyte for further 
investigation on its concentration and pH in 
parallel with accumulation parameters (potential 
and time), which influenced the peak current 
magnitude most on preliminary measurements. 
 
Table 1 presents a Central Composite Face 
experiment design with these 4 factors. While 
implementing this experiment design, other 
voltammetric parameters were kept constant. In 
Figures 2 and 3, response surface plots for the 
influence of the interaction of buffer pH with 
concentration, accumulation potential with time 
on the magnitude of the peak current measured 
are shown for DP-AdCSV and SW-AdCSV 
techniques, respectively. 
 
The optimal parameters generated for the 
minimum current peak recorded with 0.1 g/ml 
ciprofloxacin are summarized in Table 2 for both 
techniques.  
 
Validation and application 
 
A linear correlation between the voltammetric 
peak intensity and drug concentration was 
obtained over the range 0.05 – 0.15 g/ml 
(Figures 4 A and B, and Table 3). 
 
Repeatability and intermediate precision of the 
described stripping voltammetric techniques 
were examined by performing six replicate 
measurements of 0.08 µg/ml ciprofloxacin over 
one day (intraday assay) and for three 
successive days (interday assay), then 
calculating the relative standard deviation (RSD 
< 2%) for the concentrations obtained. The 
statistical comparison of voltammetric and liquid 
chromatographic techniques was done by the 
Student’s t-test and Snedecor's F-test at a 95% 
confidence level (Table 4).  No marked changes 
was observed under the influence of small 
variation (5%) of the most important variables i.e. 
buffer pH and concentration, accumulation time 
and potential. 
 
For the determination of ciprofloxacin in spiked 
human urine, the above-mentioned optimal 
experiment conditions were also applied. No 
reduction wave was seen in the range of from – 
1.3 to – 1.5 V with pure urine water-diluted by 
1250 times (blank) (Figures 5 A and B). The 
calibration curve for this analysis was 
constructed in the range 0.01 – 0.20 g/ml 
(Table 2). Analyte peak was identifiable, discrete 
and reproducible at this concentration (RSD < 
20 % and recovered within 80 – 120 %). The 
precision (RSD < 15%) and accuracy (85 - 
115%). 
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Table 1: A Central Composite Face experiment design for voltammetric measurements of 0.1 µg/mL 
ciprofloxacin 
 
No. Buffer  Accumulation  Current (µA)  
 pH Concentration (M) Potential (V) Time (s) DP-AdCSV SW-AdCSV 
1 3 0.06 – 1.3 50  – 5.102 – 4.230  
2 4 0.06 – 1.3 50  – 5.203 – 4.010 
3 3 0.1 – 1.3 50  – 4.987 – 4.020 
4 4 0.1 – 1.3 50  – 5.121 – 4.010 
5 3 0.06 – 0.9 50  – 4.890 – 3.950 
6 4 0.06 – 0.9 50  – 5.090 – 4.150 
7 3 0.1 – 0.9 50  – 4.923 – 3.450 
8 4 0.1 – 0.9 50  – 4.914 – 3.700 
9 3 0.06 – 1.3 100  – 4.201 – 5.102 
10 4 0.06 – 1.3 100  – 3.462 – 5.203 
11 3 0.1 – 1.3 100  – 3.382 – 4.987 
12 4 0.1 – 1.3 100  – 3.402 – 5.121 
13 3 0.06 –  0.9 100  – 4.103 – 4.890 
14 4 0.06 –  0.9 100  – 3.301 – 5.090 
15 3 0.1 –  0.9 100  – 3.421 – 4.923 
16 4 0.1 –  0.9 100  – 3.918 – 4.870 
17 3 0.06 – 1.1 75  – 4.563 – 4.570 
18 4 0.06 – 1.1 75  – 4.569 – 4.630 
19 3.5 0.06 – 1.1 75  – 4.890 – 4.890 
20 3.5 0.1 – 1.1 75  – 4.872 – 4.872 
21 3.5 0.08 – 1.3 75  – 4.456 – 4.456 
22 3.5 0.08 – 0.9 75  – 4.472 – 4.502 
23 3.5 0.08 – 1.1 50  – 6.102 – 6.000 
24 3.5 0.08 – 1.1 100  – 4.113 – 4.210 
25 3.8 0.08 – 1.1 75  – 5.324 – 5.324 
26 3.8 0.08 – 1.1 75  – 5.432 – 5.320 
27 3.8 0.08 – 1.1 75  – 5.351 – 5.351 
 
Table 2: Optimal parameters for voltammetric measurements of 0.1 µg/ml ciprofloxacin 
 
Parameter DP-AdCSV SW-AdCSV 
Buffer pH 3.6 3.6  
Buffer concentration 0.08 M 0.08 M 
Accumulation potential – 1.1 V – 1.1 V 
Accumulation time 50 s 100 s 
Pulse amplitude 0.1 V 0.1 V 
Frequency 50 Hz 20 Hz 
Pulse step 0.005 V 0.005 V 
Potential range – 1.1 →  – 1.6 V – 1.1 →  – 1.6 V 
 
 
         
 
Figure 2: Response surface plots for the influence of buffer pH and concentration (accumulation potential – 1.1 V 
and accumulation time 50 s) (A), and accumulation potential and time (buffer pH 3.6 and concentration 0.08 M) 
(B) on DP-AdCSV peak current of 0.1 g/mL ciprofloxacin 
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Figure 3: Response surface plots for the influence of buffer pH and concentration (accumulation potential – 1.1 V 
and accumulation time 100 s) (A), and accumulation potential and time (buffer pH 3.6 and concentration 0.08 M) 
(B) on SW-AdCSV peak current of 0.1 g/ml ciprofloxacin 
        
Figure 4: DP-AdCSV (A) and SW-AdCSV (B) measurements of 0.05 – 0.15 g/ml ciprofloxacin in 0.08 M acetate 
buffer pH 3.6 
 
Table 3: Linearity statistical analysis for the proposed voltammetric techniques 
 
Parameter Pharmaceutical formulation Spiked human urine 
 DP-AdCSV SW-AdCSV DP-AdCSV SW-AdCSV 
Concentration range (g/mL) 0.05 – 0.15 0.05 – 0.15 0.01 – 0.20 0.01 – 0.20 
Number of data points, n 6 6 7 7 
Coefficient of determination, R2 0.9964 0.9906 0.9984 0.9977 
Slope –15.700 – 24.271 – 18.282 – 15.877 
Intercept – 1.258 – 0.758 – 1.159 – 1.661 
SD of the residuals, Sy/x 0.0395 0.0990 0.05793 0.0603 
SD of the slope, Sa 0.4726 1.1840 0.32590 0.3394 
SD of the intercept, Sb 0.0499 0.1251 0.03404 0.0355 
Table 4: Assay results for the determination of ciprofloxacin in pharmaceutical formulations by the 




Recovery  SD % (n = 6)  
(t (0.05, 10) = 2.228, F (0.05, 5, 5) = 5.050) 
 USP-HPLC DP-AdCSV  SW-AdCSV 
Ciprobay 
500 mg/tablet 
101.3 ± 1.1 102.1 ± 0.9 
t = 1.379 
F = 1.494 
101.5 ± 1.2 
t = 0.301 
F = 1.190 
Quindrops 
0.3% 
101.9 ± 1.5 101.3 ± 1.0 
t = 0.815 
F = 2.250 
100.9 ± 1.1 
t = 1.317 
F = 1.860 
Intravenous 
infusion  
2 mg/ml  
101.1 ± 1.6 101.9 ± 0.9 
t = 1.067 
F = 3.160 
101.5 ± 1.0 
t = 0.519 
F = 2.560 
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Figures 5: DP-AdCSV (A) and SW-AdCSV (B) measurements of 0.01 – 0.20 g/ml ciprofloxacin in 
spiked human urine 
 
were obtained from the back calculation of other 
calibration standards.  
 
This analysis was also intraday and interday 
validated with four spiked quality control (QC) 
samples (Table 5). The relative analytical 
recovery (comparing the measured concentration 
with actual added ones) of these techniques was 
within the range 85 – 115% with RSD < 15%. 
Interestingly, the percentage absolute analytical 
recovery of the proposed DP-AdCSV and SW-
AdCSV techniques (comparing the absolute peak 
intensity of ciprofloxacin from a spiked urine 
sample to the absolute peak intensity of an 
equivalent aqueous standard) was within the 
range 95 – 100%.  
 
Table 5: Accuracy and precision data for the determination of ciprofloxacin in spiked with 
Human urine by the proposed voltammetric techniques (n = 3) 
 





as RSD (%) 
Accuracy (%) 
 DP-AdCSV 
Intraday  0.01 0.011 ± 0.004 3.7 107.4 
 0.025 0.024 ± 0.001 1.0 96.6 
 0.10 0.097 ± 0.001 1.0 96.7 
 0.16 0.167 ± 0.001 1.9 104.4 
Interday 0.01 0.011 ± 0.002 1.0 106.7 
 0.025 0.024 ± 0.008 2.0 97.8 
 0.10 0.095 ± 0.009 4.5 95.4 
 0.16 0.016 ± 0.008 1.0 98.9 
 SW-AdCSV 
Intraday  0.01 0.009 ± 0,001 4.4 90.0 
 0.025 0.025 ± 0,001 2.4 98.8 
 0.10 0.100 ± 0,002 2.0 99.8 
 0.16 0.160 ± 0.003 1.9 100.4 
Interday 0.01 0.009 ± 0,001 0.1 90.0 
 0.025 0.025 ± 0,001 0.8 98.9 
 0.10 0.100 ± 0,001 1.0 99.7 




Cyclic voltammetric data strongly indicates that 
ciprofloxacin adsorbs readily onto the surface of 
HMDE, and a considerable increase in sensitivity 
can be gained by adsorptive stripping 
voltammetry. The peak potential (Ep) shifted to 
more negative values and broadened upon the 
increase of medium pH revealing the 
involvement of protons in the electrode reaction, 
and that the proton-transfer reaction precedes 
the electron transfer [15]. The irreversible nature 
of the electrode process is confirmed as no 
oxidation peak observed. In the acidic medium, 
ciprofloxacin must be in protonated forms and its 
reduction pathway at the mercury electrode could 
be postulated according to the following reaction 
(Scheme 1). 
 
Given the fact that two electrons (na = 2) and two 
proton (m = 2) are involved in the rate- 
determining step of the electro-reduction process 
of ciprofloxacin as explained above, - value of  
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Scheme 1: Proposed mechanism of ciprofloxacin reduction at the mercury electrode 
 
0.88 was estimated from the slope value (67 mV 
/ pH) of the (Ep) vs. (pH) plot. 
 
In our study, the selection of acetate buffer as a 
supporting electrolyte is in an agreement with 
previously reported data [13]. Optimization data 
show that a minimum current peak of 0.1 µg/ml 
ciprofloxacin reached when the values of buffer 
pH, concentration and accumulation potential 
were the middle points of the ranges 
investigated. In contrast, 50 and 100 s were the 
ideal choice of accumulation time to DP-AdCSV 
and SW-AdCSV techniques for optimal 
sensitivity, respectively. This could be attributed 
to the difference in frequencies used in these 
techniques.  
 
Under the optimized conditions presented in 
Table 2, the proposed voltammetric techniques 
(DP-AdCSV and SW-AdCSV) were validated 
according to ICH guidelines [16]. RSD < 2 % 
means that the proposed voltammetric 
techniques were precise. Accuracy was 
assessed by comparing the voltammetric results 
with US pharmacopoeia HPLC [17] considered 
as a well-characterized procedure [16] when 
quantitatively analyzing ciprofloxacin in various 
pharmaceutical formulations. No statistically 
significant differences was observed between 
these techniques suggesting that DP-AdCSV and 
SW-AdCSV could be used for the routine 
analysis of ciprofloxacin pharmaceutical 
formulations in place of HPLC. In addition, these 
voltammetric techniques were fairly robust as 
reflected by its capacity to remain unaffected by 
small variation of the most important variables. 
The determination of ciprofloxacin in spiked 
human urine was specific as the matrix influence 
of diluted human urine to its voltammetric 
measurement was not considerable. For this 
analysis, the construction of the calibration curve 
was based on the fact that urine concentrations 
of unchanged ciprofloxacin are approximately 30 
– 200 g/ml within 2 – 10 h after a 250 mg oral 
dose [18]. As a consequence of this linear range, 
the sensitivity (Lower Limit Of Quantification – 
LLOQ) was 0.01 g/ml for both DP-AdCSV and 
SW-AdCSV techniques. Clearly, the validation 
data support that DP-AdCSV and SW-AdCSV 
determination of ciprofloxacin in human urine 
satisfactorily meets the requirement for assay 




The mechanism of electro-reduction of 
ciprofloxacin at the HMDE was elucidated. Using 
0.08 M acetate buffer pH 3.6 as a supporting 
electrolyte, DP-AdCSV and SW-AdCSV 
techniques were developed for the determination 
of ciprofloxacin in bulk powder, pharmaceutical 
dosage forms and spiked human urine without 
any prerequisite extraction, separation and 
adsorption steps. Votammetric data were 
statistically comparable to pharmacopoeia HPLC 
suggesting that the determination of ciprofloxacin 
was accurate, precise and without interferences 
from excipients. Moreover, the sensitivity and 
reliability of the determination of ciprofloxacin in 
spiked human urine sample was also acceptable. 
Hence, the validated techniques could be 
recommended for use in quality control and 
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